BTK and malignant colon neoplasm: We showed, that MM-129 exerts its favorable effect on colon cancer cells by inhibiting their crucial signaling pathways, such as PI3K/AKT/mTOR and Bruton’s tyrosine kinase (BTK), together with decreasing PD-L1 expression [16].